Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
What’s Behind Cannabis Stock HERB? (click to learn more) Eshbal Acquires a 55% Interest in Dare to Be Different Foods (click to learn more) CSE: ALEN.U — AI Meets Digital Health (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Kaleido Biosciences Inc (EM) KLDO

Healthcare Biotechnology
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic... see more

Current News (EXPM:KLDO)

Radius Health Announces Leadership Appointments

GlobeNewswire March 16, 2022

Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs

PR Newswire February 28, 2022

INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT

PR Newswire February 15, 2022

Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohn's and Colitis Congress

GlobeNewswire January 21, 2022

Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT(TM)) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions

GlobeNewswire December 6, 2021

Kaleido Biosciences to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

GlobeNewswire November 15, 2021

Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer

GlobeNewswire November 10, 2021

Kaleido Biosciences Reports Third Quarter 2021 Financial Results

GlobeNewswire November 1, 2021

Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change

PR Newswire October 13, 2021
View More News ››

Opinion & Analysis (EXPM:KLDO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:KLDO)

4 BIOTECH STOCKS FOR YOUR INVESTMENT WATCHLIST!

4 BIOTECH STOCKS FOR YOUR INVESTMENT WATCHLIST! FSTX, RIGL, CRNX, KLDO,  Read More
AviseAnalytics - August 9, 2021
View more Bullboard ››

Pelangio Exploration Inc.

Pelangio Exploration Inc.

Pelangio Exploration Inc., a mineral exploration company, engages in the acquisition, exploration, and development of mineral ...
View More »

Podcasts